Clinical trialNCT05639933RecruitingPhase 2Interventional

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

SponsorHoth Therapeutics, Inc.Enrollment152Acneiform Eruption Due to ChemicalParonychiaXerosis Cutis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mario Lacouture, MD
NYU Langone Health
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Poland

Centrum Medyczne Pratia Krakow
Krakow, Poland
Active, not recruiting
Nzoz Neuromed M. I M. Nastaj Sp.P
Lublin, Poland
Active, not recruiting

Spain

Hospital Sant Joan de Deu-Fundacio Althaia
Manresa, Spain
Active, not recruiting

United States

Uci Health - Ciacc
Irvine, California, United States
Janellen Smith, MD
Recruiting
Uc Irvine - Chao Family Cancer Center
Orange, California, United States
Janellen Smith, MD
Recruiting
Regis Clinical Research
Miami, Florida, United States
Yilena Rodriguez, MD
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Connie Shi, MD
Recruiting
Nyu Langone Health
Mineola, New York, United States
Mario Lacouture, MD →
Recruiting
Northwell Physician Partners Dermatology
New Hyde Park, New York, United States
Sheila Shaigany, MD
Recruiting
Montefiore Medical Center
The Bronx, New York, United States
Beth McLellan, MD
Recruiting
Gabrail Cancer & Research Center
Canton, Ohio, United States
Nashat Gabrail, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Anisha Patel, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Jul 2023
Primary completion: 30 Dec 2026
Completion: 30 Dec 2026
Last update posted: 31 Mar 2026
Registered enrollment: 152
Registry id: NCT05639933

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.